Acellular Pertussis Vaccine Components: Today and Tomorrow

Area of Science:

• Immunology
• Epidemiology
• Vaccinology

Background:

• Pertussis, a highly contagious respiratory infection caused by Bordetella pertussis, poses a significant global health challenge.
• Immunity to pertussis, whether from natural infection or vaccination, is not lifelong, leading to recurrent outbreaks.
• The evolution from whole-cell pertussis (wP) to acellular pertussis (aP) vaccines has impacted disease control strategies.

Purpose of the Study:

• To review the epidemiology of pertussis before and after the implementation of wP and aP vaccines.
• To discuss the scientific rationale and clinical considerations for antigen selection in aP vaccines.
• To provide an overview of emerging vaccine technologies for improved pertussis prevention.

Main Methods:

• Literature review of pertussis epidemiology and vaccine history.
• Analysis of vaccine composition and efficacy data.
• Synthesis of current research on novel pertussis vaccine candidates.

Main Results:

• Pertussis epidemiology has been significantly influenced by the introduction and widespread use of wP and aP vaccines.
• The shift to aP vaccines has implications for immune response duration and outbreak patterns.
• Ongoing research is exploring new vaccine platforms and antigens to enhance pertussis immunity.

Conclusions:

• Effective control of pertussis requires ongoing monitoring of disease epidemiology and vaccine effectiveness.
• Understanding the limitations of current vaccines is crucial for developing improved strategies.
• Novel vaccine approaches hold promise for achieving more durable and broad protection against pertussis.